Kestra Medical Technologies (KMTS) Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Revenue data on file, last reported at $28.6 million in Q2 2026.

• On a quarterly basis, Revenue rose 66.18% year-over-year to $28.6 million in Q2 2026; TTM through Apr 2026 was $95.1 million, a 59.03% increase from a year earlier, with the FY2026 full-year figure at $95.1 million, up 59.03% from the prior year.
• Revenue for Q2 2026 stood at $28.6 million, up from $24.6 million in the prior quarter.
• Over the last five years, Revenue for KMTS reached as high as $28.6 million in Q2 2026 and fell as low as $8.3 million in Q1 2024.
• Historically, Revenue has averaged $17.3 million across 3 years, with a median of $16.2 million in 2025.
• On a YoY basis, Revenue climbed as much as 82.31% in 2025 and fell as far as 51.55% in 2025.
• Year by year, Revenue stood at $14.7 million in 2024, then surged by 53.4% to $22.6 million in 2025, then rose by 26.91% to $28.6 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $28.6 million in Q2 2026, $24.6 million in Q1 2026, and $22.6 million in Q4 2025.